Uni-Bio Science Group Limited (HKG:0690)
Hong Kong · Delayed Price · Currency is HKD 0.0730
0.00 (0.00%)
Sep 18, 2026, 3:59 PM HKT
Uni-Bio Science Group Employees
Uni-Bio Science Group had 568 employees as of June 30, 2026. The number of employees increased by 25 or 4.60% since the number was reported on December 31, 2025.
Employees
568
Change
25
Growth
4.60%
Revenue / Employee
967.90K HKD
Profits / Employee
85.46K HKD
Market Cap
435.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 568 | 25 | 4.60% |
| Dec 31, 2025 | 543 | 56 | 11.50% |
| Dec 31, 2024 | 487 | 80 | 19.66% |
| Dec 31, 2023 | 407 | 37 | 10.00% |
| Dec 31, 2022 | 370 | 44 | 13.50% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| JW (Cayman) Therapeutics Co. | 303 |
| Cutia Therapeutics | 268 |
| Immunotech Biopharm | 189 |
| 3D Medicines | 162 |
| Transcenta Holding | 150 |
| Kintor Pharmaceutical | 122 |
| Brii Biosciences | 80 |
| Wuhan YZY Biopharma | 68 |
Uni-Bio Science Group News
- 25 days ago - Uni-Bio Science Group Reports Revenue Decline As Biopharmaceutical Pipeline Advances - Nasdaq
- 1 year ago - Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches : Pioneering Entry into the High-Growth Medical Aesthetics Market - Zawya